c a laboratories limited
c a laboratories limited Company Information
Company Number
07585607
Next Accounts
Apr 2025
Directors
Shareholders
brendan michael john bride
susan bride
View AllGroup Structure
View All
Industry
Dental practice activities
Registered Address
40a station road, upminster, essex, RM14 2TR
Website
www.salltd.co.ukc a laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of C A LABORATORIES LIMITED at £387.8k based on a Turnover of £741.9k and 0.52x industry multiple (adjusted for size and gross margin).
c a laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of C A LABORATORIES LIMITED at £64.7k based on an EBITDA of £19.6k and a 3.3x industry multiple (adjusted for size and gross margin).
c a laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of C A LABORATORIES LIMITED at £81.2k based on Net Assets of £31.2k and 2.6x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
C A Laboratories Limited Overview
C A Laboratories Limited is a dissolved company that was located in essex, RM14 2TR with a Companies House number of 07585607. It operated in the dental practice activities sector, SIC Code 86230. Founded in March 2011, it's largest shareholder was brendan michael john bride with a 40% stake. The last turnover for C A Laboratories Limited was estimated at £741.9k.
Upgrade for unlimited company reports & a free credit check
C A Laboratories Limited Health Check
Pomanda's financial health check has awarded C A Laboratories Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
5 Weak
Size
annual sales of £741.9k, make it in line with the average company (£754.8k)
- C A Laboratories Limited
£754.8k - Industry AVG
Growth
3 year (CAGR) sales growth of -3%, show it is growing at a slower rate (-0.2%)
- C A Laboratories Limited
-0.2% - Industry AVG
Production
with a gross margin of 43.1%, this company has a comparable cost of product (49.7%)
- C A Laboratories Limited
49.7% - Industry AVG
Profitability
an operating margin of 2.6% make it less profitable than the average company (5.1%)
- C A Laboratories Limited
5.1% - Industry AVG
Employees
with 7 employees, this is below the industry average (11)
7 - C A Laboratories Limited
11 - Industry AVG
Pay Structure
on an average salary of £17.9k, the company has an equivalent pay structure (£17.9k)
- C A Laboratories Limited
£17.9k - Industry AVG
Efficiency
resulting in sales per employee of £106k, this is more efficient (£68.6k)
- C A Laboratories Limited
£68.6k - Industry AVG
Debtor Days
it gets paid by customers after 57 days, this is later than average (9 days)
- C A Laboratories Limited
9 days - Industry AVG
Creditor Days
its suppliers are paid after 106 days, this is slower than average (27 days)
- C A Laboratories Limited
27 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- C A Laboratories Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - C A Laboratories Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 82.5%, this is a higher level of debt than the average (50.5%)
82.5% - C A Laboratories Limited
50.5% - Industry AVG
C A LABORATORIES LIMITED financials
C A Laboratories Limited's latest turnover from March 2021 is estimated at £741.9 thousand and the company has net assets of £31.2 thousand. According to their latest financial statements, C A Laboratories Limited has 7 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 7 | 8 | 13 | 16 | 17 | 13 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 60,082 | 67,093 | 81,324 | 17,546 | 25,547 | 42,145 | 58,762 | 31,205 | 533 | 711 |
| Intangible Assets | ||||||||||
| Investments & Other | ||||||||||
| Debtors (Due After 1 year) | ||||||||||
| Total Fixed Assets | 60,082 | 67,093 | 81,324 | 17,546 | 25,547 | 42,145 | 58,762 | 31,205 | 533 | 711 |
| Stock & work in progress | ||||||||||
| Trade Debtors | 116,460 | 96,760 | 92,386 | 81,090 | 92,064 | 118,039 | 75,735 | 98,186 | 85,549 | |
| Group Debtors | ||||||||||
| Misc Debtors | 2,173 | 2,173 | 10,434 | 52,169 | 90,485 | 73,565 | 23,932 | 22,348 | ||
| Cash | 19,326 | 20,503 | ||||||||
| misc current assets | ||||||||||
| total current assets | 118,633 | 98,933 | 92,386 | 81,090 | 102,498 | 189,534 | 166,220 | 192,254 | 109,481 | 22,348 |
| total assets | 178,715 | 166,026 | 173,710 | 98,636 | 128,045 | 231,679 | 224,982 | 223,459 | 110,014 | 23,059 |
| Bank overdraft | 5,567 | |||||||||
| Bank loan | ||||||||||
| Trade Creditors | 123,511 | 109,662 | 77,234 | 88,600 | 57,561 | 21,321 | 116,807 | 112,379 | 69,157 | 22,899 |
| Group/Directors Accounts | ||||||||||
| other short term finances | ||||||||||
| hp & lease commitments | ||||||||||
| other current liabilities | 45,808 | 184,045 | ||||||||
| total current liabilities | 123,511 | 109,662 | 77,234 | 88,600 | 108,936 | 205,366 | 116,807 | 112,379 | 69,157 | 22,899 |
| loans | 8,262 | 23,986 | ||||||||
| hp & lease commitments | ||||||||||
| Accruals and Deferred Income | 4,860 | 4,860 | 4,860 | |||||||
| other liabilities | 19,112 | 36,148 | 65,927 | 5,364 | 6,000 | 50,664 | 18,000 | |||
| provisions | ||||||||||
| total long term liabilities | 23,972 | 41,008 | 70,787 | 5,364 | 8,262 | 29,986 | 50,664 | 18,000 | ||
| total liabilities | 147,483 | 150,670 | 148,021 | 93,964 | 117,198 | 235,352 | 167,471 | 130,379 | 69,157 | 22,899 |
| net assets | 31,232 | 15,356 | 25,689 | 4,672 | 10,847 | -3,673 | 57,511 | 93,080 | 40,857 | 160 |
| total shareholders funds | 31,232 | 15,356 | 25,689 | 4,672 | 10,847 | -3,673 | 57,511 | 93,080 | 40,857 | 160 |
| Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 16,598 | 16,617 | 16,643 | 7,835 | 178 | 236 | ||||
| Amortisation | ||||||||||
| Tax | ||||||||||
| Stock | ||||||||||
| Debtors | 19,700 | 6,547 | 11,296 | -21,408 | -67,710 | 3,988 | -5,531 | 62,270 | 87,133 | 22,348 |
| Creditors | 13,849 | 32,428 | -11,366 | 31,039 | 36,240 | -95,486 | 4,428 | 43,222 | 46,258 | 22,899 |
| Accruals and Deferred Income | 4,860 | -45,808 | -138,237 | 184,045 | ||||||
| Deferred Taxes & Provisions | ||||||||||
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | ||||||||||
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | ||||||||||
| Group/Directors Accounts | ||||||||||
| Other Short Term Loans | ||||||||||
| Long term loans | -8,262 | -15,724 | 23,986 | |||||||
| Hire Purchase and Lease Commitments | ||||||||||
| other long term liabilities | -17,036 | -29,779 | 60,563 | 5,364 | -6,000 | -44,664 | 32,664 | 18,000 | ||
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | -19,326 | 19,326 | -20,503 | 20,503 | ||||||
| overdraft | -5,567 | 5,567 | ||||||||
| change in cash | 5,567 | -24,893 | 19,326 | -20,503 | 20,503 |
c a laboratories limited Credit Report and Business Information
C A Laboratories Limited Competitor Analysis
Perform a competitor analysis for c a laboratories limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other undefined companies, companies in RM14 area or any other competitors across 12 key performance metrics.
c a laboratories limited Ownership
C A LABORATORIES LIMITED group structure
C A Laboratories Limited has no subsidiary companies.
Ultimate parent company
C A LABORATORIES LIMITED
07585607
c a laboratories limited directors
C A Laboratories Limited currently has 1 director, Mr Brendan Bride serving since Mar 2011.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Brendan Bride | United Kingdom | 63 years | Mar 2011 | - | Director |
P&L
March 2021turnover
741.9k
+14%
operating profit
19.6k
0%
gross margin
43.1%
-1.91%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2021net assets
31.2k
+1.03%
total assets
178.7k
+0.08%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
c a laboratories limited company details
company number
07585607
Type
Private limited with Share Capital
industry
86230 - Dental practice activities
incorporation date
March 2011
age
14
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2021
previous names
N/A
accountant
-
auditor
-
address
40a station road, upminster, essex, RM14 2TR
Bank
-
Legal Advisor
-
c a laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to c a laboratories limited.
c a laboratories limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for C A LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.
c a laboratories limited Companies House Filings - See Documents
| date | description | view/download |
|---|
